Ennov announces its inclusion in four 2019 Life Science market research reports published by Gartner, Inc. the leading information technology research and advisory company. The following reports recognize Ennov solutions:
Life Sciences CIOs and IT leaders across the globe face growing pressures to demonstrate value from their technology initiatives. They must link IT to specific business outcomes such as sales force effectiveness, maximizing revenue and profitability, reducing operating costs, responding to and complying with regulations, and achieving higher R&D productivity. These reports focus on the issues that Life Sciences CIOs face as they strive to digitally transform their organizations to address these business priorities.
Specifically, Ennov was recognized for our leadership in Quality Management System (QMS), Regulatory Information Management (RIM), Electronic Trial Master File (eTMF), eClinical and Safety Vigilance software.
According to Ennov CEO Olivier Pâris,
“We are once again very happy to be recognized by Gartner in their 2019 Life Sciences Market Research Reports. Our inclusion in these reports illustrates our commitment to transforming the digital future of the industry through our suite of innovative and unified solutions.”
Ennov provides Life Sciences companies with comprehensive and robust content, data and process management solutions that span the entire product development value chain. Our solutions are built on our unified compliance platform and represent the industry best practices that we have accumulated over 15 years of serving the Life Sciences user community.
Headquartered in Paris, with offices in the US and UK, Ennov provides the most intuitive, comprehensive, and cost-effective suite of software solutions for the life sciences industry. From leading pharmaceutical companies to emerging biotechnology companies, we proudly serve over 150 companies and 150,000 users around the world. Our solutions are designed and built to support the entire Life Sciences R&D continuum including Clinical, Regulatory, Quality, Pharmacovigilance and Commercial.